Report overview
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system?s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine. This report contains market size and forecasts of Veterinary Vaccine in global, including the following market information:
Global Veterinary Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Veterinary Vaccine Market Sales, 2018-2023, 2024-2029, (M Doses)
Global top five Veterinary Vaccine companies in 2022 (%)
The global Veterinary Vaccine market was valued at US$ 8544.4 million in 2022 and is projected to reach US$ 12710 million by 2029, at a CAGR of 5.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Veterinary Vaccine key players include Merck, Boehringer Ingelheim, Zoetis, Ceva, Elanco, etc. Global top five manufacturers hold a share about 75%. North America and Asia Pacific is the largest market, both with a share about 30%, followed by Europe, with a share about 25 percent. In terms of product, Live Attenuated Vaccines is the largest segment, with a share about 60%. And in terms of application, the largest application is Dog & Cat, followed by Livestock, Swine, Chicken, etc.
We surveyed the Veterinary Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Veterinary Vaccine Market Segment Percentages, by Type, 2022 (%)
Live Attenuated Vaccines
Inactivated Vaccines
Others
Global Veterinary Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Veterinary Vaccine Market Segment Percentages, by Application, 2022 (%)
Livestock
Swine
Chicken
Dog & Cat
Others
Global Veterinary Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Veterinary Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Veterinary Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Veterinary Vaccine revenues share in global market, 2022 (%)
Key companies Veterinary Vaccine sales in global market, 2018-2023 (Estimated), (M Doses)
Key companies Veterinary Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
BioTestLab
RVSRI
Medion
Outline of Major Chapters:
Chapter 1: Introduces the definition of Veterinary Vaccine, market overview.
Chapter 2: Global Veterinary Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Veterinary Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Veterinary Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
